Jane Street
IBRX icon

Jane Street’s ImmunityBio IBRX Stock Holding History

Jane Street’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.26M Buy
946,200
+415,800
+78% +$2.85M ﹤0.01% 2961
2025
Q4 		$1.05M Sell
530,400
-51,300
-9% -$116K ﹤0.01% 6019
2025
Q3 		$1.43M Sell
581,700
-2,700
-0.5% -$6.95K ﹤0.01% 5563
2025
Q2 		$1.54M Buy
584,400
+475,300
+436% +$1.28M ﹤0.01% 4846
2025
Q1 		$328K Buy
109,100
+34,800
+47% +$105K ﹤0.01% 7645
2024
Q4 		$190K Sell
74,300
-589,800
-89% -$2.46M ﹤0.01% 8449
2024
Q3 		$2.47M Buy
664,100
+511,500
+335% +$2.37M ﹤0.01% 4047
2024
Q2 		$964K Sell
152,600
-29,700
-16% -$196K ﹤0.01% 5842
2024
Q1 		$979K Sell
182,300
-682,700
-79% -$3.09M ﹤0.01% 5453
2023
Q4 		$4.34M Buy
865,000
+672,500
+349% +$2.11M ﹤0.01% 3048
2023
Q3 		$325K Sell
192,500
-400,100
-68% -$803K ﹤0.01% 6948
2023
Q2 		$1.65M Buy
592,600
+554,000
+1,435% +$1.57M ﹤0.01% 4460
2023
Q1 		$70.3K Sell
38,600
-32,700
-46% -$102K ﹤0.01% 8352
2022
Q4 		$361K Sell
71,300
-10,600
-13% -$58.2K ﹤0.01% 6691
2022
Q3 		$407K Buy
81,900
+9,300
+13% +$42.4K ﹤0.01% 7059
2022
Q2 		$270K Buy
72,600
+25,400
+54% +$102K ﹤0.01% 7774
2022
Q1 		$265K Sell
47,200
-62,800
-57% -$385K ﹤0.01% 8587
2021
Q4 		$669K Buy
110,000
+19,900
+22% +$150K ﹤0.01% 6721
2021
Q3 		$878K Sell
90,100
-1,700
-2% -$18.7K ﹤0.01% 6177
2021
Q2 		$1.31M Sell
91,800
-65,100
-41% -$1.08M ﹤0.01% 5226
2021
Q1 		$3.73M Buy
156,900
+31,100
+25% +$806K ﹤0.01% 2867
2020
Q4 		$1.68M Buy
125,800
+93,300
+287% +$897K ﹤0.01% 3807
2020
Q3 		$225K Sell
32,500
-10,900
-25% -$109K ﹤0.01% 6280
2020
Q2 		$533K Buy
+43,400
New +$245K ﹤0.01% 4993

Other funds holding IBRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Jane Street's IBRX Position: Q1 2026 in Review

Jane Street reduced its ImmunityBio (IBRX) stake by 95% in Q1 2026, selling an estimated $92.6M and leaving 704,232 shares worth $5.4M. The position accounts for ﹤0.01% of the portfolio, ranked #3393.

Jane Street first reported a position in IBRX in Q2 2019 and has held it in 24 quarters since. The position peaked at $31.6M in Q3 2025. 386 funds tracked by Wall St. Rank hold IBRX as of Q1 2026.

  • Jane Street held 704,232 shares of ImmunityBio worth $5.4M as of Q1 2026.
  • Jane Street sold 13,519,992 ImmunityBio shares in Q1 2026, an estimated $92.6M.
  • ImmunityBio made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #3393 holding.
  • Jane Street first reported a position in ImmunityBio in Q2 2019 and has held it in 24 quarters since.
  • Jane Street's ImmunityBio position peaked at $31.6M in Q3 2025.
  • 386 funds tracked by Wall St. Rank held ImmunityBio as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.